Oncology Revenue Cycle Management Services
Manage Your Entire Practice On A Single Platform
With an affordable all in one solution for in-office and remote patient care. PracticeSuite provides flexible workflows to help organize your practice and keep it operating at peek efficiency; as well as a complete end to end virtual practice that allows you to treat any patient, anywhere, on any device.
Do you feel your in-house medical billing processes could be better?
ls it challenging to keep up with aging AR?
Need more staff or more expertise for your complex medical billing?
Over, 15,000 medical professionals from solo practitioners to large groups and medical centers rely on PracticeSuite’s cloud based medical billing technology to efficiently run their practice. Every feature required to run 150 different practice specialties is available but the system allows you to customize and simplify screens to see only what you want and need in each area of the software.
We never share your information with anyone
Tomorrow’s Oncology Practice Software TODAY
What is Oncology Software?
Designed to electronically store patient medical information, oncology software is an essential part of every oncologist’s practice. Ideally, the software not only takes into account the unique needs of oncologists, it also helps them spend more time with patients. But no matter how modern or feature-filled an electronic medical record (EMR) is, unless it easily integrates with all other software used in the oncology practice—everything from medical devices to billing software—it’s not a good choice.
Tomorrow’s Software Today
Today’s patients expect simple, fast, multi-channel communication with all their providers, along with virtual visits when appropriate. To keep up, oncology practices must provide secure text and chat for appointment making, automated appointment reminders, electronic registration, mobile check-in, telehealth connected to EMR, and automated e-billing and statements.
How Can Modern EMRs Benefit Oncologists?
- Simplify coding. EMRs that are difficult to learn, counterintuitive to use, and require multiple steps for simple tasks leads to physician burnout faster than any other issue. Oncologists are especially vulnerable to this phenomenon because of coding complexity and encounter frequency. They need software that improves efficiency by quickly leading them through the process to enter, for example, a radiation treatment category or type of neoplasm.
- Improve care coordination. Given that it’s perhaps the most complex of the medical specialties, it’s no surprise that care coordination was cited by oncologists as the most important aspect of the EMR, followed by symptom management and screening services.
- Improve patient-physician interactions. A survey conducted by the Association of Community Cancer Centers found that 41% of oncologists believe EMRs have had a negative impact on provider-patient interactions during appointments. To be effective, these tools must be so easy to use that oncologists can record key patient information during encounters while maintaining a meaningful conversation with the patient.
- Improve treatment-plan creation. Choosing a treatment plan requires gathering data from multiple sources, but few EMRs allow oncologists to easily bring all relevant information together to aid in treatment selection. Look for systems that facilitate this process and allow oncologists to use decision support to aid in treatment selection.
- Improve practice management. Features like note-taking templates, PQRI reporting functions, clinical decision support, and patient-progress dashboards all help oncologists create practice-specific workflows that help them spend more time with patients and less on administrative tasks.
- Improve revenue cycle management (RCM). You may think you need more staff or expertise to solve your A/R issues—the truth is today’s technology can identify and fix lost revene from patient balances and unpaid claims; benchmark your reimbursement rates; and help you understand how to increase patient satisfaction, increase revenue on routine appointments, and reduce no-shows.
What’s the Biggest Mistake Oncologists Make When Choosing an Office Solution?
No matter how modern or feature-filled a system is, unless it is integrated with all other office software used in the oncology clinic, it will not be able to give you the granular data you need for RCM. Put simply, the oncology office software you select should help providers:
- Provide in-office and remote patient care
- Quickly create superbills
- Easily track revenue to avoid leaks
- Create customized notetaking templates
- Create dashboards to track patient progress
- Easily gather data from a variety of imaging devices
Lastly, the oncology office system should be able to quickly integrate with patient-facing systems such as patient portals and personal electronic medical records.
ICD-10 Oncology Superbill Example
|Appointment Date & Time:||Last Seen Date:|
|Patient:||Gender:||DOB:||MR#||Pat Due:||INS Due:|
|Home Phone:||Cell Phone:||E-Mail:|
|Case Name:||Case No:||Case Type:||Case Date:|
|Pr Insurance:||Member ID:||Co-Pay Amount:||Deductible:|
|Rendering Provider:||PCP:||Referring Provider:|
|CPT Code||Description||CPT Code||Description||CPT Code||Description|
|61796||Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion||77331||Special dosimetry (e.g., TLD, microdosimetry) (specify), only when prescribed by the treating physician||77414||Radiation treatment delivery; three or more separate treatment areas; custom blocking, tangential ports wedges, rotational beam, compensators, electron beam; 11-19 MV Complex|
|61797||Each additional cranial lesion, simple (List separately in addition to code for primary procedure)||77332||Treatment devices, design and construction; simple (simple block, simple bolus)||77416||Radiation treatment delivery; three or more separate treatment areas; custom blocking, tangential ports wedges, rotational beam, compensators, electron beam; 20 MV or greater|
|61798||1 complex cranial lesion||77333||Intermediate (multiple blocks, stents, bite blocks, special bolus)||77417||Therapeutic radiology port film(s)|
|61799||Each additional cranial lesion, complex (List separately in addition to code for primary procedure)||77334||Complex (irregular blocks, special shields, compensators, wedges, molds or casts)||77418||Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session|
|77261||Therapeutic radiology treatment planning; simple||77336||Continuing medical physics consultation, including assessment of treatment parameters, quality assurance of dose delivery, and review of patient treatment documentation in support of the radiation oncologist, reported per week of therapy||77421||Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy|
|77262||Therapeutic Radiology treatment planning; intermediate||77370||Special medical radiation physics consultation||77422||High energy neutron radiation treatment delivery; single treatment area using a single port or parallel-opposed ports with no blocks or simple blocking|
|77263||Therapeutic Radiology treatment planning; complex||77371||Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; multi-source Cobalt 60 based||77423||1 or more isocenter(s) with coplanar or non-coplanar geometry with blocking and/or wedge, and/or compensator(s)|
|77280||Therapeutic radiology simulation-aided field setting; simple||77372||Linear accelerator based||77427||Radiation treatment management, 5 treatments|
|77285||Intermediate||77373||Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions||77431||Radiation therapy management with complete course of therapy consisting of 1 or 2 fractions only|
|77290||Therapeutic Radiology Simulation; complex||77399||Unlisted procedure, medical radiation physics, dosimetry and treatment devices, and special services||77432||Stereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of 1 session)|
|77295||Therapeutic Radiology Simulation 3-Dimensional||77401||Radiation treatment delivery, superficial and/or ortho voltage||77435||Stereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions|
|77299||Unlisted procedure, therapeutic radiology clinical treatment planning||77402||Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks; up to 5||77470||Special treatment procedure (e.g., total body irradiation, hemibody radiation, per oral, endocavitary or intraoperative cone irradiation)|
|77300||Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician||77403||Radiation treatment delivery; single treatment area, single port or parallel opposed ports, simple blocks or no blocks;6-10 MeV||77499||Unlisted procedure, therapeutic radiology treatment management|
|77301||Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications||77404||Radiation treatment delivery; single treatment area, single port or parallel opposed ports, simple blocks or no blocks;11-19 MeV||77520||Proton treatment delivery; simple, without compensation|
|77305||Teletherapy, isodose plan (whether hand or computer calculated); simple (1 or 2 parallel opposed unmodified ports directed to a single area of interest)||77406||20 MeV or greater||77522||Proton treatment delivery, simple w/ compensation|
|77310||Intermediate (3 or more treatment ports directed to a single area of interest)||77407||Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks; up to 5 MeV||77523||Proton treatment delivery, intermediate|
|77315||Complex (mantle or inverted Y, tangential ports, the use of wedges, compensators, complex blocking, rotational beam, or special beam considerations)||77408||Radiation treatment delivery; two separate treatment areas, three or more ports on a single treatment area use of multiple blocks6-10 MeV||77525||Proton treatment delivery, complex|
|77321||Special teletherapy port plan, particles, hemibody, total body||77409||Radiation treatment delivery; two separate treatment areas, three or more ports on a single treatment area use of multiple blocks11-19 MeV||G0173||Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session|
|77326||Brachytherapy isodose plan; simple (calculation made from single plane, 1 to 4 sources/ribbon application, remote afterloading brachytherapy, 1 to 8 sources)||77411||Radiation treatment delivery; two separate treatment areas, three or more ports on a single treatment area use of multiple blocks: 20 MeV or greater||G0251||Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment|
|77327||Intermediate (multiplane dosage calculations, application involving 5 to 10 sources/ribbons, remote afterloading brachytherapy, 9 to 12 sources)||77412||Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 MeV||G0339||Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment|
|77328||Complex (multiplane isodose plan, volume implant calculations, over 10 sources/ribbons used, special spatial reconstruction, remote afterloading brachytherapy, over 12 sources)||77413||Radiation treatment delivery; three or more separate treatment areas; custom blocking, tangential ports wedges, rotational beam, compensators, electron beam; 6-10 MV Complex||G0340||Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment|
|C50.919||Malignant neoplasm of unspecified site of unspecified female breast||C92.40||Acute promyelocytic leukemia, not having achieved remission||D46.9||Myelodysplastic syndrome, unspecified|
|C50.911||Malignant neoplasm of unspecified site of right female breast||C92.50||Acute myelomonocytic leukemia, not having achieved remission||D46.Z||Other myelodysplastic syndromes|
|C50.912||Malignant neoplasm of unspecified site of left female breast||C92.60||Acute myeloid leukemia with 11q23-abnormality not having achieved remission||D69.3||Immune thrombo cytopenic purpura|
|C50.921||Malignant neoplasm of unspecified site of right male breast||C92.A0||Acute myeloid leukemia with multilineage dysplasia,not having achieved remission||D70.9||Neutropenia, unspecified|
|C50.922||Malignant neoplasm of unspecified site of left male breast||Z31.5||Encounter for genetic counseling||D61.818||Other pancytopenia|
|C50.929||Malignant neoplasm of unspecified site of unspecified male breast||C18.9||Malignant neoplasm of colon, unspecified||C91.00||Acute lymphoblastic leukemia not having achieved remission|
|C34.90||Malignant neoplasm of unspecified part of unspecified bronchus or lung||C20||Malignant neoplasm of rectum||D47.2||Monoclonal gammopathy|
|Z77.22||Exposure to environmental tobacco smoke||F43.23||Adjustment disorder with mixed anxiety and depressed mood||D89.2||Hypergammaglobulinemia, unspecified|
|P96.81||Exposure to tobacco smoke in the perinatal period||C61||Malignant neoplasm of prostate||M31.1||Thrombotic micro angiopathy|
|Z87.891||History of tobacco use||126.99||Other pulmonary emblism without acute cor pulmonale||C10.9||Malignant neoplasm of oropharynx, unspecified|
|Z57.31||Occupational exposure to environmental tobacco smoke||126.09||Other pulmonary embolism with acutew cor pulmonale||D45||Polycythemia vera|
|Z72.0||Tobacco use||C43.9||Malignant melanoma of skin, unspecified||C22.1||Intrahepatic bile duct carcinoma|
|C34.91||Malignant neoplasm of unspecified part of right bronchus or lung||D03.9||Melanoma in situ, unspecified||B16.-, B18.0-818.1||Hepatitis B|
|C34.92||Malignant neoplasm of unspecified part of left bronchus or lung||C91.10||Chronic lympocytic leukemia of B-cell type not having achieved remission||B17.1-, B18.2||Hepatitis C|
|C85.80||Other specified types of non-Hodgkin lymphoma, unspecified site||C71.9||Malignant neoplasm of brain,unspecified||C82.90||Follicular lymphoma, unspecified, unspecified site|
|C85.89||Other specified types of non-Hodgkin lymphoma,extranodal and solid organ sites||197.2||Postmastectomy lymphedema syndrome||C82.99||Follicular lymphoma, unspecified, extranodal and solid organ sites|
|C82.50||Diffuse follicle center lymphoma, unspecified site||C15.9||Malignant neoplasm of esophagus, unspecified||C82.00||Follicular lymphoma grade I, unspecified site|
|C82.59||Diffuse follicle center lymphoma, extranodal and solid organ sites||D69.6||Thrombocytopenia,unspecified||C82.09||Follicular lymphoma grade I, extranodal and solid organ sites|
|C84.90||Mature T/NK-cell lymphomas, unspecified, unspecified site||D64.9||Anemia,Unspecified||C82.10||Follicular lymphoma grade II, unspecified site|
|C84.99||Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites||182.409||Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity||C82.19||Follicular lymphoma grade II, extranodal and solid organ sites|
|C84.A0||Cutaneous T-cell lymphoma, unspecified, unspecified site||182.401||Acute embolism and thrombosis of unspecified deep veins of right lower extremity||C82.20||Follicular lymphoma grade III, unspecified, unspecified site|
|C84.A9||Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites||182.402||Acute embolism and thrombosis of unspecified deep veins of left lower extremity||C82.29||Follicular lymphoma grade III, unspecified, extranodal and solid organ sites|
|C84.Z0||Other mature T/NK-cell lymphomas, unspecified site||182.403||Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral||C82.30||Follicular lymphoma grade Illa, unspecified site|
|C84.Z9||Other mature T/NK-cell lymphomas, extranodal and solid organ sites||C49.9||Malignant neoplasm of connective and soft tissue,unspecified||C82.39||Follicular lymphoma grade Illa, extranodal and solid organ sites|
|C85.10||Unspecified B-cell lymphoma, unspecified site||C47.9||Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified||C82.40||Follicular lymphoma gradelllb, unspecified site|
|C85.19||Unspecified B-cell lymphoma, extranodal and solid organ sites||C81.90||Hodgkin lymphoma,unspecified,unspecified site||C82.49||Follicular lymphoma gradelllb, extranodal and solid organ sites|
|C85.20||Mediastinal (thymic) large B-cell lymphoma, unspecified site||C81.99||Hodgkinlymphoma,unspecified,extranodal and solid organ sites||C82.60||Cutaneous follicle center lymphoma, unspecified site|
|C85.29||Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites||189.0||Lymphedema,not elsewhere classified||C82.69||Cutaneous follicle center lymphoma, extranodal and solid organ sites|
|C85.90||Non-Hodgkin lymphoma, unspecified, unspecified site||C67.9||Malignant neoplasm of bladder,unspecified||C82.80||Other types of follicular lymphoma, unspecified site|
|C85.99||Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites||C64.9||Malignant neoplasm of unspecified kidney, except renal pelvis||C82.89||Other types of follicular lymphoma, extranodal and solid organ sites|
|C86.4||Blastic NK-cell lymphoma||C64.1||Malignant neoplasm of right kidney, except renal pelvis||C90.01||Multiple myeloma in remission|
|289.81||Primary hypercoagulable state||C64.2||Malignant neoplasm of left kidney, except renal pelvis||C88.0||Waldenstrom macroglobulinemia|
|D68.51||Activated protein C resistance||D47.3||Essential (hemorrhagic)thrombocythemia||C06.89||Malignant neoplasm of overlapping sites of other parts of mouth|
|D68.52||Prothrombin gene mutation||Z51.11||Encounter for antineoplastic chemotherapy||C06.80||Malignant neoplasm of overlapping sites of unspecified parts of mouth|
|D68.59||Other primary thrombophilia||C62.10||Malignant neoplasm of unspecified descended testis||D59.0||Drug-induced autoimmune hemolytic anemia|
|D68.61||Antiphospholipid syndrome||C62.90||Malignant neoplasm of unspecified testis, unspecified||D59.1||Other autoimmune hemolytic anemias|
|D68.62||Lupus anticoagulant syndrome||C62.11||Malignant neoplasm of descended right testis||C83.39||Diffuse large B-cell lymphoma, extranodal and solid organ sites|
|157.9||Malignant neoplasm of pancreas, part unspecified||C62.12||Malignant neoplasm of descended left testis||C85.20||Mediastinal (thymic) large B-cell lymphoma, unspecified site|
|C25.9||Malignant neoplasm of pancreas, unspecified||C62.91||Malignant neoplasm of right testis, unspecified whether descended or undescended||C85.29||Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites|
|C90.00||Multiple myeloma not having achieved remission||C62.92||Malignant neoplasm of left testis, unspecified whether descended or undescended||C84.00||Mycosis fungoides, unspecified site|
|C92.00||Acute myeloblastic leukemia, not having achieved remission||D50.9||Iron deficiency unspecified anemia, unspecified||C84.09||Mycosis fungoides, extranodal and solid organ sites|
|C92.10||Chronic myeloid leukemia, BCR/ABL- positive, not having achieved remission||C16.9||Malignant neoplasm of stomach, unspecified||C32.9||Malignant neoplasm of larynx, unspecified|
- Jercich, Kat. “After-Hours Charting Significantly Associated With Physician Burnout.” Healthcare IT News, 23 April 2021. https://www.healthcareitnews.com/news/after-hours-charting-significantly-associated-physician-burnout
- Green, Jeff. “Five Oncology EHRs to Kickstart Your Selection Shortlist.” EHR in Practice, 15 July 2021. https://www.ehrinpractice.com/top-oncology-ehrs.html
- “Highlights from the 2018 Trending Now in Cancer Care Survey.” Association of Community Cancer Centers. 2019. https://www.accc-cancer.org/docs/documents/surveys/trends-in-cancer-programs-2018-highlights.pdf?sfvrsn=beaab989_2
- Hassett, Michael. “Usability Considerations in Oncology Electronic Medical Records.” JCP Oncology Practice, 2 March, 2017. https://ascopubs.org/doi/10.1200/JOP.2017.024745